Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Experience with Fingolimod in Clinical Practice.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
A passive exoskeleton can push your life up: application on multiple sclerosis patients.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis.
LSN MS guidelines for the management of multiple sclerosis.
Alemtuzumab treatment of multiple sclerosis.
[Optic Neuritis.]
Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Mitochondrial dysfunction in central nervous system white matter disorders.
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
[Spasticity and everyday life in multiple sclerosis].
Modulation of B Cell Regulatory Molecules CD22 and CD72 in Myasthenia Gravis and Multiple Sclerosis.
Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis.
The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
The Latest Innovations in the Drug Pipeline for Multiple Sclerosis.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Effect of the time of day on central and peripheral fatigue during 2-min maximal voluntary contractions in persons with multiple sclerosis: gender differences.

Pages